In the latest quarter, 15 analysts provided ratings for BioNTech (NASDAQ:BNTX), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 9 | 1 | 4 | 1 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 4 | 1 | 3 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 1 | 0 |
| 3M Ago | 2 | 0 | 1 | 0 | 0 |
Analysts have set 12-month price targets for BioNTech, revealing an average target of $121.33, a high estimate of $150.00, and a low estimate of $85.00. Marking an increase of 18.26%, the current average surpasses the previous average price target of $102.60.
Diving into Analyst Ratings: An In-Depth Exploration
A comprehensive examination of how financial experts perceive BioNTech is derived from recent analyst actions...
Login or create a forever free account to read this news
Sign up/Log in